chr9-34647853-CT-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000155.4(GALT):c.400delT(p.Trp134GlyfsTer4) variant causes a frameshift change. The variant allele was found at a frequency of 0.000013 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000155.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- classic galactosemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- galactosemiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALT | NM_000155.4 | c.400delT | p.Trp134GlyfsTer4 | frameshift_variant | Exon 5 of 11 | ENST00000378842.8 | NP_000146.2 | |
GALT | NM_001258332.2 | c.73delT | p.Trp25GlyfsTer4 | frameshift_variant | Exon 3 of 9 | NP_001245261.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALT | ENST00000378842.8 | c.400delT | p.Trp134GlyfsTer4 | frameshift_variant | Exon 5 of 11 | 1 | NM_000155.4 | ENSP00000368119.4 | ||
ENSG00000258728 | ENST00000556278.1 | c.253-261delT | intron_variant | Intron 2 of 7 | 5 | ENSP00000451792.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251494 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461892Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727246 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase Pathogenic:2
This sequence change creates a premature translational stop signal (p.Trp134Glyfs*4) in the GALT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALT are known to be pathogenic (PMID: 22944367). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with galactosemia (PMID: 25592817). ClinVar contains an entry for this variant (Variation ID: 25171). For these reasons, this variant has been classified as Pathogenic. -
- -
Galactosemia Pathogenic:1
- -
not provided Pathogenic:1
The GALT c.400delT;p.Trp134fs variant is reported in the medical literature in several individuals, including individuals with classic galactosemia (Bosch 2005, Tyfield 1999, Viggiano 2015). The variant is listed in the ClinVar database (Variation ID: 25171) and in the dbSNP variant database (rs111033689) but not described in the general population-based databases (Exome Variant Server, Genome Aggregation Database). This variant deletes one nucleotide, creating a frameshift, and is predicted to result in a truncated protein or mRNA subject to non-sense mediated decay. Considering available information, this variant is classified as pathogenic. References: Bosch AM et al. Identification of novel mutations in classical galactosemia. Hum Mutat. 2005 May;25(5):502. Tyfield L et al. Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat. 1999;13(6):417-30. Viggiano E et al. Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy: structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene. Gene. 2015 Apr 1;559(2):112-8. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at